Intensive group-based cognitive therapy in patients with cardiac disease and psychological distress-a randomized controlled trial protocol
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Intensive group-based cognitive therapy in patients with cardiac disease and psychological distress-a randomized controlled trial protocol. / Holdgaard, Annette; Eckhardt-Hansen, Christine; Lund, Thomas; Lassen, Christina Funch; Sibiliz, Kirstine Laerum; Hofsten, Dan Eik; Prescott, Eva; Rasmusen, Hanne Kruuse.
I: Trials, Bind 22, Nr. 1, 455, 2021.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Intensive group-based cognitive therapy in patients with cardiac disease and psychological distress-a randomized controlled trial protocol
AU - Holdgaard, Annette
AU - Eckhardt-Hansen, Christine
AU - Lund, Thomas
AU - Lassen, Christina Funch
AU - Sibiliz, Kirstine Laerum
AU - Hofsten, Dan Eik
AU - Prescott, Eva
AU - Rasmusen, Hanne Kruuse
PY - 2021
Y1 - 2021
N2 - Background: Many patients with coronary artery disease (CAD) and valvular heart disease (VHD) suffer from psychological distress. Such stress is associated with increased morbidity, reduced quality of life and delayed return to work. European guidelines emphasize recognition and intervention, but evidence-based treatment options are limited and perceived as costly. The present study will test the effect of brief, group-based cognitive therapy as an adjunct to usual cardiac rehabilitation in a randomized design.Methods: A total of 148 patients with CAD and/or VHD after surgical intervention and concomitant psychological distress (defined as HADS anxiety (A) or depression (D) score >= 8) will be randomized to either usual out-patient cardiac rehabilitation (CR) comprising an 8-week multidisciplinary programme or usual care supplemented by five group-based cognitive therapy sessions performed by trained CR nurses. A structured, standardized treatment manual will be used. Patients will be randomized 1:1 at three different sites. Additionally, a non-randomized sub-group of 40 matched patients without signs of psychological distress will be followed to investigate spontaneous variation in HADS. The primary outcome is Hospital Anxiety and Depression Score (HADS). Secondary outcomes are adherence to cardiac rehabilitation (CR), health-related quality of life measured by HeartQoL, time to return to work, adherence to lifestyle interventions and cardiovascular readmissions. Patients are followed up for 12 months.Discussion: To our knowledge, this is the first randomized controlled trial (RCT) on patients with cardiac disease with an intensive group-based programme of cognitive therapy performed by CR nurses, which makes it affordable and widely implementable. The outcome will elucidate the feasibility and effect of cognitive therapy as an adjunct to CR in patients with post-surgery CAD and/or VHD and psychological distress and could possibly benefit patients with other heart conditions as well. The clinical trial complies with the Declaration of Helsinki. The trial has been approved by The Regional Research Ethics Committee (file number H-16042832) and The Danish Data Protection Agency. The results will be disseminated as original research in peer-reviewed manuscripts.
AB - Background: Many patients with coronary artery disease (CAD) and valvular heart disease (VHD) suffer from psychological distress. Such stress is associated with increased morbidity, reduced quality of life and delayed return to work. European guidelines emphasize recognition and intervention, but evidence-based treatment options are limited and perceived as costly. The present study will test the effect of brief, group-based cognitive therapy as an adjunct to usual cardiac rehabilitation in a randomized design.Methods: A total of 148 patients with CAD and/or VHD after surgical intervention and concomitant psychological distress (defined as HADS anxiety (A) or depression (D) score >= 8) will be randomized to either usual out-patient cardiac rehabilitation (CR) comprising an 8-week multidisciplinary programme or usual care supplemented by five group-based cognitive therapy sessions performed by trained CR nurses. A structured, standardized treatment manual will be used. Patients will be randomized 1:1 at three different sites. Additionally, a non-randomized sub-group of 40 matched patients without signs of psychological distress will be followed to investigate spontaneous variation in HADS. The primary outcome is Hospital Anxiety and Depression Score (HADS). Secondary outcomes are adherence to cardiac rehabilitation (CR), health-related quality of life measured by HeartQoL, time to return to work, adherence to lifestyle interventions and cardiovascular readmissions. Patients are followed up for 12 months.Discussion: To our knowledge, this is the first randomized controlled trial (RCT) on patients with cardiac disease with an intensive group-based programme of cognitive therapy performed by CR nurses, which makes it affordable and widely implementable. The outcome will elucidate the feasibility and effect of cognitive therapy as an adjunct to CR in patients with post-surgery CAD and/or VHD and psychological distress and could possibly benefit patients with other heart conditions as well. The clinical trial complies with the Declaration of Helsinki. The trial has been approved by The Regional Research Ethics Committee (file number H-16042832) and The Danish Data Protection Agency. The results will be disseminated as original research in peer-reviewed manuscripts.
KW - Coronary heart disease
KW - Cardiac rehabilitation
KW - HADS
KW - Depression
KW - Anxiety
KW - Psychological distress
KW - Cognitive therapy
KW - OF-LIFE QUESTIONNAIRE
KW - BEHAVIORAL THERAPY
KW - DEPRESSION SCALE
KW - HOSPITAL ANXIETY
KW - RISK-FACTOR
KW - HEALTH
KW - STATEMENT
KW - OUTCOMES
KW - CARE
KW - RECOMMENDATIONS
U2 - 10.1186/s13063-021-05405-3
DO - 10.1186/s13063-021-05405-3
M3 - Journal article
C2 - 34271952
VL - 22
JO - Trials
JF - Trials
SN - 1745-6215
IS - 1
M1 - 455
ER -
ID: 275122774